Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66


Optimal dose-fractionation schedule of palliative radiotherapy for patients with bone metastases: a protocol for systematic review and network meta-analysis.

Tang X, Hu Q, Chen Y, Wang X, Li X, Cheng K, Cao D.

BMJ Open. 2020 Jan 6;10(1):e033120. doi: 10.1136/bmjopen-2019-033120.


Short Term Exposure to Bilirubin Induces Encephalopathy Similar to Alzheimer's Disease in Late Life.

Chen H, Liang L, Xu H, Xu J, Yao L, Li Y, Tan Y, Li X, Huang Q, Yang Z, Wu J, Chen J, Huang H, Wang X, Zhang CE, Liu J.

J Alzheimers Dis. 2020;73(1):277-295. doi: 10.3233/JAD-190945.


Mixed-Solvent Polarity-Assisted Phase Transition of Cesium Lead Halide Perovskite Nanocrystals with Improved Stability at Room Temperature.

Yun R, Luo L, He J, Wang J, Li X, Zhao W, Nie Z, Lin Z.

Nanomaterials (Basel). 2019 Oct 30;9(11). pii: E1537. doi: 10.3390/nano9111537.


4-Aryl Pyrrolidines as Novel Orally Efficacious Antimalarial Agents. Part 2: 2-Aryl-N-(4-arylpyrrolidin-3-yl)acetamides.

Meyers MJ, Liu J, Liu Z, Ma H, Dai L, Adah D, Zhao S, Li X, Liu X, Lu Y, Huang Y, Tu Z, Chen X, Tortorella MD.

ACS Med Chem Lett. 2019 May 28;10(6):966-971. doi: 10.1021/acsmedchemlett.9b00123. eCollection 2019 Jun 13.


Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network meta-analysis of randomized controlled trials.

Hu Q, Wang X, Chen Y, Li X, Cao P, Cao D.

Medicine (Baltimore). 2019 May;98(21):e15761. doi: 10.1097/MD.0000000000015761.


Plasmodium infection inhibits the expansion and activation of MDSCs and Tregs in the tumor microenvironment in a murine Lewis lung cancer model.

Adah D, Yang Y, Liu Q, Gadidasu K, Tao Z, Yu S, Dai L, Li X, Zhao S, Qin L, Qin L, Chen X.

Cell Commun Signal. 2019 Apr 12;17(1):32. doi: 10.1186/s12964-019-0342-6.


4-Aryl Pyrrolidines as a Novel Class of Orally Efficacious Antimalarial Agents. Part 1: Evaluation of 4-Aryl- N-benzylpyrrolidine-3-carboxamides.

Meyers MJ, Liu J, Xu J, Leng F, Guan J, Liu Z, McNitt SA, Qin L, Dai L, Ma H, Adah D, Zhao S, Li X, Polino AJ, Nasamu AS, Goldberg DE, Liu X, Lu Y, Tu Z, Chen X, Tortorella MD.

J Med Chem. 2019 Apr 11;62(7):3503-3512. doi: 10.1021/acs.jmedchem.8b01972. Epub 2019 Mar 22.


Localization of TMC1 and LHFPL5 in auditory hair cells in neonatal and adult mice.

Li X, Yu X, Chen X, Liu Z, Wang G, Li C, Wong EYM, Sham MH, Tang J, He J, Xiong W, Liu Z, Huang P.

FASEB J. 2019 Jun;33(6):6838-6851. doi: 10.1096/fj.201802155RR. Epub 2019 Feb 26.


A new gold(I) complex-Au(PPh3)PT is a deubiquitinase inhibitor and inhibits tumor growth.

Li X, Huang Q, Long H, Zhang P, Su H, Liu J.

EBioMedicine. 2019 Jan;39:159-172. doi: 10.1016/j.ebiom.2018.11.047. Epub 2018 Dec 5.


Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma.

Li X, Li X, Fang X, Yuan Y.

Onco Targets Ther. 2018 Jul 16;11:4047-4050. doi: 10.2147/OTT.S154567. eCollection 2018.


Rapid water disinfection over a Ag/AgBr/covalent triazine-based framework composite under visible light.

Li L, Li X, Cheng Z, Bi J, Liang S, Zhang Z, Yu Y, Wu L.

Dalton Trans. 2018 May 22;47(20):7077-7082. doi: 10.1039/c8dt01070f.


Identification of Kininogen 1 as a Serum Protein Marker of Colorectal Adenoma in Patients with a Family History of Colorectal Cancer.

Yu J, Huang Y, Lin C, Li X, Fang X, Zhong C, Yuan Y, Zheng S.

J Cancer. 2018 Mar 8;9(3):540-547. doi: 10.7150/jca.22405. eCollection 2018.


Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII).

Koltun DO, Parkhill EQ, Kalla R, Perry TD, Elzein E, Li X, Simonovich SP, Ziebenhaus C, Hansen TR, Marchand B, Hung WK, Lagpacan L, Hung M, Aoyama RG, Murray BP, Perry JK, Somoza JR, VillaseƱor AG, Pagratis N, Zablocki JA.

Bioorg Med Chem Lett. 2018 Feb 1;28(3):541-546. doi: 10.1016/j.bmcl.2017.10.040. Epub 2017 Oct 20.


Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer.

Hu W, Yang Y, Li X, Huang M, Xu F, Ge W, Zhang S, Zheng S.

Mol Cancer Res. 2018 Mar;16(3):476-485. doi: 10.1158/1541-7786.MCR-17-0483. Epub 2017 Nov 29.


Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.

Yu J, Zhai X, Li X, Zhong C, Guo C, Yang F, Yuan Y, Zheng S.

Sci Rep. 2017 Oct 27;7(1):14265. doi: 10.1038/s41598-017-14539-x.


CLCA1 suppresses colorectal cancer aggressiveness via inhibition of the Wnt/beta-catenin signaling pathway.

Li X, Hu W, Zhou J, Huang Y, Peng J, Yuan Y, Yu J, Zheng S.

Cell Commun Signal. 2017 Oct 3;15(1):38. doi: 10.1186/s12964-017-0192-z.


Discriminating patients with early-stage breast cancer from benign lesions by detection of oxidative DNA damage biomarker in urine.

Guo C, Li X, Ye M, Xu F, Yu J, Xie C, Cao X, Guo M, Yuan Y, Zheng S.

Oncotarget. 2017 May 12;8(32):53100-53109. doi: 10.18632/oncotarget.17831. eCollection 2017 Aug 8.


The complex of TRIP-Br1 and XIAP ubiquitinates and degrades multiple adenylyl cyclase isoforms.

Hu W, Yu X, Liu Z, Sun Y, Chen X, Yang X, Li X, Lam WK, Duan Y, Cao X, Steller H, Liu K, Huang P.

Elife. 2017 Jun 28;6. pii: e28021. doi: 10.7554/eLife.28021.


Bilirubin neurotoxicity is associated with proteasome inhibition.

Huang H, Guo M, Liu N, Zhao C, Chen H, Wang X, Liao S, Zhou P, Liao Y, Chen X, Lan X, Chen J, Xu D, Li X, Shi X, Yu L, Nie Y, Wang X, Zhang CE, Liu J.

Cell Death Dis. 2017 Jun 15;8(6):e2877. doi: 10.1038/cddis.2017.274.

Supplemental Content

Loading ...
Support Center